Trials / Completed
CompletedNCT01334853
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
A Prospective Observational Study to Assess the Role of Selected Biomarkers in Subjects Requiring Daily Medium- to High-dose Inhaled Corticosteroids for Persistent Asthma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 97 (actual)
- Sponsor
- MedImmune LLC · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The rationale for conducting this study is to explore potential clinical and peripheral biomarkers in subjects requiring daily medium to high dose inhaled corticosteroids for persistent asthma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No drug will be used | Biomarker |
| OTHER | No drug will be used | Biomarker |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-04-01
- Completion
- 2012-09-01
- First posted
- 2011-04-13
- Last updated
- 2012-10-11
Locations
18 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01334853. Inclusion in this directory is not an endorsement.